Literature DB >> 31412296

SOX2 in development and cancer biology.

Daniel Novak1, Laura Hüser1, Jonathan J Elton1, Viktor Umansky1, Peter Altevogt1, Jochen Utikal2.   

Abstract

The transcription factor SOX2 is essential for embryonic development and plays a crucial role in maintaining the stemness of embryonic cells and various adult stem cell populations. On the other hand, dysregulation of SOX2 expression is associated with a multitude of cancer types and it has been shown that SOX2 positively affects cancer cell traits such as the capacity to proliferate, migrate, invade and metastasize. Moreover, there is growing evidence that SOX2 mediates resistance towards established cancer therapies and that it is expressed in cancer stem cells. These findings indicate that studying the role of SOX2 in the context of cancer progression could lead to the development of new therapeutic options. In this review, the current knowledge about the role of SOX2 in development, maintenance of stemness, cancer progression and the resistance towards cancer therapies is summarized.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cancer; Development; Sox2; Stem cell; Tumor

Year:  2019        PMID: 31412296     DOI: 10.1016/j.semcancer.2019.08.007

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  54 in total

1.  SOX2 expression in the pathogenesis of premalignant lesions of the uterine cervix: its histo-topographical distribution distinguishes between low- and high-grade CIN.

Authors:  Jobran M Moshi; Monique Ummelen; Jos L V Broers; Frank Smedts; Koen K Van de Vijver; Jack P M Cleutjens; Rogier J N T M Litjens; Frans C S Ramaekers; Anton H N Hopman
Journal:  Histochem Cell Biol       Date:  2022-08-09       Impact factor: 2.531

2.  CDC20 is a novel biomarker for improved clinical predictions in epithelial ovarian cancer.

Authors:  Xiaoxue Xi; Tianyue Cao; Yonghong Qian; Huiling Wang; Songwen Ju; Youguo Chen; Ting Chen; Jian Yang; Biaoquan Liang; Shunyu Hou
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

3.  In Ovo Injection of CHIR-99021 Promotes Feather Follicle Development via Modulating the Wnt Signaling Pathway and Transcriptome in Goose Embryos (Anser cygnoides).

Authors:  Ziqiang Feng; Haizhou Gong; Jinhong Fu; Xiaohui Xu; Yupu Song; Xiaomin Yan; Ichraf Mabrouk; Yuxuan Zhou; Yudong Wang; Xianou Fu; Yujian Sui; Tuoya Liu; Chuanghang Li; Zebei Liu; Xu Tian; Le Sun; Keying Guo; Yongfeng Sun; Jingtao Hu
Journal:  Front Physiol       Date:  2022-05-20       Impact factor: 4.755

Review 4.  RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness.

Authors:  Huarong Chen; Yifei Wang; Hao Su; Xiaoting Zhang; Hongyan Chen; Jun Yu
Journal:  Front Cell Dev Biol       Date:  2022-07-04

5.  A mechanistic basis for the malignant progression of salivary gland tumors.

Authors:  Sachiko Taniguchi; Yuya Tanaka; Ajit Elhance; Naoki Oshimori
Journal:  iScience       Date:  2021-11-25

6.  Sox2 Is an Oncogenic Driver of Small-Cell Lung Cancer and Promotes the Classic Neuroendocrine Subtype.

Authors:  Ellen Voigt; Madeline Wallenburg; Hannah Wollenzien; Ethan Thompson; Kirtana Kumar; Joshua Feiner; Moira McNally; Hunter Friesen; Malini Mukherjee; Yohannes Afeworki; Michael S Kareta
Journal:  Mol Cancer Res       Date:  2021-09-30       Impact factor: 6.333

7.  Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells.

Authors:  Garry L Coles; Sandra Cristea; James T Webber; Rebecca S Levin; Steven M Moss; Andy He; Jaya Sangodkar; Yeonjoo C Hwang; Julia Arand; Alexandros P Drainas; Nancie A Mooney; Janos Demeter; Jessica N Spradlin; Brandon Mauch; Vicky Le; Yan Ting Shue; Julie H Ko; Myung Chang Lee; Christina Kong; Daniel K Nomura; Michael Ohlmeyer; Danielle L Swaney; Nevan J Krogan; Peter K Jackson; Goutham Narla; John D Gordan; Kevan M Shokat; Julien Sage
Journal:  Cancer Cell       Date:  2020-06-11       Impact factor: 31.743

8.  The actinomycin D molecule docks to a hydrophilic section of the SOX2 high-mobility group (HMG) domain.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

Review 9.  Proliferation Increasing Genetic Engineering in Human Corneal Endothelial Cells: A Literature Review.

Authors:  Wout Arras; Hendrik Vercammen; Sorcha Ní Dhubhghaill; Carina Koppen; Bert Van den Bogerd
Journal:  Front Med (Lausanne)       Date:  2021-06-29

10.  Expression of SOX2 and OCT4 in odontogenic cysts and tumors.

Authors:  Ekarat Phattarataratip; Tarit Panitkul; Watunyoo Khodkaew; Pattarapong Anupuntanun; Jirapat Jaroonvechatam; Sirawit Pitarangsikul
Journal:  Head Face Med       Date:  2021-07-14       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.